Recent Finacing
Recent Raise
DiogenX is a Marseille‑based preclinical biotech with research labs in Nice developing Wnt/β‑catenin–targeting small molecules to stimulate pancreatic beta‑cell regeneration for insulin‑dependent diabetes.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at DiogenX.
